Market Overview:
The global enteral feeding devices market size reached US$ 4.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 6.6 Billion by 2032, exhibiting a growth rate (CAGR) of 5.6% during 2024-2032.
Report Attribute
|
Key Statistics
|
Base Year
|
2023
|
Forecast Years
|
2024-2032
|
Historical Years
|
2018-2023
|
Market Size in 2023 |
US$ 4.0 Billion |
Market Forecast in 2032 |
US$ 6.6 Billion |
Market Growth Rate (2024-2032) |
5.6% |
Enteral feeding devices refer to various tools and equipment used for the delivery of nutrients directly into the digestive tract through a feeding tube. This technique is primarily used for patients experiencing difficulties in the oral intake of food products, liquids and nutritional supplements. Some of the commonly used enteral feeding devices include feeding pumps, tubes, giving sets, enteral syringes and consumables. These devices enable consistent and accurate delivery of food containing proteins, carbohydrates, fats, water, minerals and vitamins. In comparison to the traditionally used polyvinylchloride feeding tubes, novel silicon-based variants are more flexible and do not cause irritation upon exposure to digestive enzymes.
The increasing prevalence of chronic diseases, such as diabetes, cancer and gastrointestinal ailments, is one of the key factors driving the growth of the market. Furthermore, the rising geriatric population that is more susceptible to such medical illnesses is driving the market growth. Diseases and neurological conditions, such as multiple sclerosis, stroke and dementia, impact the patient’s ability to swallow and cause malnourishment. This has enhanced the demand for enteral feeding devices that can aid in providing nutritional support through oral supplements and feeding tubes. In line with this, the advent of home enteral nutrition is also creating a positive outlook for the market. Additionally, various technological advancements, such as the development of low-profile gastrostomy buttons that are suitable for both children and adult patients, are contributing to the market growth. Other factors, including improving healthcare infrastructure, along with the growing demand for neonatal and preterm enteral feeding devices, are expected to drive the market further.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global enteral feeding devices market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product type, age group, application and end user.
Breakup by Product Type:
- Enteral Feeding Pumps
- Enteral Feeding Tubes
- Giving Sets
- Enteral Syringes
- Consumables
- Others
Breakup by Age Group:
Breakup by Application:
- Oncology
- Gastroenterology
- Neurology
- Diabetes
- Hypermetabolism
- Others
Breakup by End User:
- Hospitals
- Ambulatory Surgery Centers
- Others
Breakup by Region:
- North America
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Amsino International Inc., B. Braun Melsungen Aktiengesellschaft (B. Braun Holding GmbH & Co. KG), BD (Becton Dickinson and Company), Boston Scientific Corporation, Cardinal Health Inc., Conmed Corporation, Fresenius Kabi Aktiengesellschaft (Fresenius SE & Co. KGaA) and Moog Inc.
Report Coverage:
Report Features |
Details |
Base Year of the Analysis |
2023 |
Historical Period |
2018-2023 |
Forecast Period |
2024-2032 |
Units |
US$ Billion |
Segment Coverage |
Product Type, Age Group, Application, End User, Region |
Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered |
Abbott Laboratories, Amsino International Inc., B. Braun Melsungen Aktiengesellschaft (B. Braun Holding GmbH & Co. KG), BD (Becton Dickinson and Company), Boston Scientific Corporation, Cardinal Health Inc., Conmed Corporation, Fresenius Kabi Aktiengesellschaft (Fresenius SE & Co. KGaA) and Moog Inc. |
Customization Scope |
10% Free Customization |
Report Price and Purchase Option |
Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899 |
Post-Sale Analyst Support |
10-12 Weeks |
Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
- How has the global enteral feeding devices market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global enteral feeding devices market?
- What are the key regional markets?
- What is the breakup of the market based on the product type?
- What is the breakup of the market based on the age group?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global enteral feeding devices market and who are the key players?
- What is the degree of competition in the industry?